The largest database of trusted experimental protocols

Fusion protein

Manufactured by Bausch & Lomb
Sourced in United States

Fusion Protein is a laboratory equipment used for the expression and purification of recombinant proteins. It combines two or more proteins or protein domains into a single polypeptide chain. Fusion Protein facilitates the isolation and characterization of target proteins by enhancing their solubility, stability, and detection.

Automatically generated - may contain errors

2 protocols using fusion protein

1

Penetrating Keratoplasty Surgical Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
PKP was performed under general anesthesia with the anesthetist's assistance. The center of the host cornea was marked and then completely excised using a Barron vacuum trephine (Katena Products, Denville, NJ). The donor corneas were cut using a punch trephine on a Troutman guide (Medtronic Solan, Jacksonville, FL). All grafts had diameters between 7.0 and 8.0 mm. All grafts were closed with a continuous 24-bite running 10-0 nylon suture.
Postoperatively, patients received tobramycin and dexamethasone eye drops (Alcon Laboratories, Fort Worth, TX) 4 times per day for 3 months and recombinant bovine basic fibroblast growth factor (Fusion Protein, Bausch and Lomb, Rochester, NY) eye gel 3 times per day for 6 months. All eyes in the PKP group were treated with mannitol 1 time postoperatively.
+ Open protocol
+ Expand
2

Corneal Lenticule Implantation After SMILE

Check if the same lab product or an alternative is used in the 5 most similar protocols
All donor tissues were collected from the eye bank of the Hainan Eye Hospital in accordance with local guidelines (Hainan Entry-Exit Inspection and Quarantine Bureau of the People's Republic of China). Topical anaesthesia consisted of proparacaine hydrochloride eye drops (Alcaine; Alcon Laboratories, Fort Worth, TX). A myopic correction of −0.75 diopters (28 μm thickness) using a femtosecond laser system under SMILE treatment was performed on the recipient cornea, and the surgical incision was 2.5 mm long. The surgeon unfolded the lenticule with microforceps and created a “stromal pocket” at a depth of 160 μm from the cornea epithelium, followed by implantation of the lenticule into the “stromal pocket.” The surgical procedures were detailed in our previous studies [13 (link), 16 (link)]. Following the surgery, all patients received tobramycin and dexamethasone (Alcon Laboratories, US) eye drops 4 times per day for 2 weeks and recombinant bovine basic fibroblast growth factor (Fusion Protein, Bausch and Lomb, Rochester, NY) eye gel 3 times per day for 6 months.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!